Sustainability | September 12, 2023
JB Pharma publishes sustainability report for FY 2022-23
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
The biopharmaceutical leader shared its expert perspective at the Equality Lounge at the G20 Summit
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
Prasugrel tablets are indicated to reduce the rate of thrombotic CV events
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
Granules India received approval from Brazilian Health Regulatory Agency ANVISA
Eris Lifesciences enters into term loan agreement with Citi Bank
Weinand is the former CEO and Chairman of the Board at Bayer Pharma AG, leading Bayer’s fully integrated $20 billion healthcare business
Subscribe To Our Newsletter & Stay Updated
